Clinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial.

Lehrl S

sleep disturbances associated with non-psychotic anxiety disorders can be effectively and safely treated with kava extract WS 1490.

Randomized Controlled Trial
3 effects
4 weeks
61 subjects

Reported Outcomes

CausesOutcomeCertainty

Kava Herb risk & protective factor
Kava
Herb

Subjective well-being Brain outcome
Minor increase risk of Subjective well-being
Brain system

Moderate evidence
3.0%

Kava Herb risk & protective factor
Kava
Herb

Sleep Musculoskeletal outcome
Minor increase risk of Sleep
Musculoskeletal system

Moderate evidence
3.0%

Kava Herb risk & protective factor
Kava
Herb

Sleep Musculoskeletal outcome
Minor increase risk of Sleep
Musculoskeletal system

Moderate evidence
1.0%